These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33614732)

  • 1. Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy.
    Feng L; Li W; Chao Y; Huan Q; Lu F; Yi W; Jun W; Binbin C; Na L; Shougang Z
    Kidney Dis (Basel); 2021 Jan; 7(1):34-49. PubMed ID: 33614732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.
    Liu F; Wang L; Qi H; Wang J; Wang Y; Jiang W; Xu L; Liu N; Zhuang S
    Clin Sci (Lond); 2017 Aug; 131(16):2125-2143. PubMed ID: 28646122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
    Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
    Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
    PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
    Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
    J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.
    Liu N; Guo JK; Pang M; Tolbert E; Ponnusamy M; Gong R; Bayliss G; Dworkin LD; Yan H; Zhuang S
    J Am Soc Nephrol; 2012 May; 23(5):854-67. PubMed ID: 22362908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation.
    Hassan NME; Said E; Shehatou GSG
    Life Sci; 2021 May; 272():119241. PubMed ID: 33600861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis.
    Liu F; Yu C; Qin H; Zhang S; Fang L; Wang Y; Wang J; Cui B; Hu S; Liu N; Zhuang S
    J Cell Mol Med; 2021 May; 25(13):6103-14. PubMed ID: 33949772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
    Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
    Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
    Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis.
    Bigaeva E; Stribos EGD; Mutsaers HAM; Piersma B; Leliveld AM; de Jong IJ; Bank RA; Seelen MA; van Goor H; Wollin L; Olinga P; Boersema M
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F117-F134. PubMed ID: 31736352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
    Makled MN; El-Kashef DH
    Life Sci; 2020 Jul; 253():117729. PubMed ID: 32348836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis.
    XIN BM; WANG XX; JIN W; YAN HM; CUI B; ZHANG XW; HUA F; YANG HZ; HU ZW
    Acta Pharmacol Sin; 2010 Dec; 31(12):1583-92. PubMed ID: 21113175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
    Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
    Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
    Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
    J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.
    You YK; Luo Q; Wu WF; Zhang JJ; Zhu HJ; Lao L; Lan HY; Chen HY; Cheng YX
    J Cell Mol Med; 2019 Aug; 23(8):5576-5587. PubMed ID: 31211499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.